1. Home
  2. EIG vs ARQT Comparison

EIG vs ARQT Comparison

Compare EIG & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

HOLD

Current Price

$42.81

Market Cap

933.9M

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.34

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIG
ARQT
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
933.9M
3.3B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
EIG
ARQT
Price
$42.81
$29.34
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.83
AVG Volume (30 Days)
320.1K
1.9M
Earning Date
10-30-2025
10-28-2025
Dividend Yield
2.98%
N/A
EPS Growth
N/A
N/A
EPS
2.58
N/A
Revenue
$904,800,000.00
$317,929,000.00
Revenue This Year
$3.75
$85.51
Revenue Next Year
N/A
$30.74
P/E Ratio
$16.65
N/A
Revenue Growth
1.69
129.21
52 Week Low
$35.73
$11.13
52 Week High
$52.29
$31.77

Technical Indicators

Market Signals
Indicator
EIG
ARQT
Relative Strength Index (RSI) 69.60 56.62
Support Level $42.71 $27.55
Resistance Level $43.51 $30.26
Average True Range (ATR) 0.69 1.07
MACD 0.22 -0.30
Stochastic Oscillator 86.75 45.09

Price Performance

Historical Comparison
EIG
ARQT

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: